New way of administering allergen in specific immunotherapy with allergens

摘要

An allergenic composition comprising an inhalation allergen or a poison allergen associated with an IgE-mediated allergy, formulated to be suitable for subcutaneous administration, for use in specific subcutaneous allergen immunotherapy comprising an increasing dosage phase and a maintenance phase, and in which a dose of the allergenic composition is administered in the increasing dosage phase to an individual who needs it by using subcutaneous infusion using a continuous flow at a flow rate exceeding 0.05 ml / min in a period in the range of 5 to 180 minutes, and in which the increasing dosage lasts from 2 to 6 weeks and the number of administrations of the individual doses in the increasing administration phase is 2 to 4.